Browse Articles
Discover research articles across all indexed journals
Fourier pixels for bidirectional light control
American science at 250
Co <sub>1</sub> /Ru Single‐Atom Alloy Catalyst for Sustainable Polypropylene Hydrogenolysis to Long‐Chain Liquid Products
ABSTRACT Achieving selective polyolefin waste hydrogenolysis into fuels and chemicals requires architectures that disrupt Ru─Ru ensembles without compromising the intrinsic activity of the state‐of‐the‐art Ru catalyst. While metal modifiers can beneficially tune selectivity, they have been shown for high promoter‐metal contents, with associated penalties in structural definition and potential practicality. Here, we engineer cobalt speciation on Ru through impregnation to disclose how promotion spans the entire compositional space realizing a titania‐supported Co 1 /Ru single‐atom alloy catalyst (Co 10 Ru 90 , 3 mol% total metal content) that resolves these trade‐offs. Ex situ and operando analyses reveal that these bimetallic ensembles containing Ru─Co─Ru sites display a distinctively high barrier for over‐hydrogenolysis at late reaction stages while preserving the intrinsic activity of Ru. As a result, virgin polypropylene and post‐consumer waste were almost fully converted with a consistently high C 11+ yield of up to 60% (78% total liquids), compared to <5% over the monometallic Ru counterpart. Process‐level simulations predict economically viable and environmentally sustainable operation enabled by the high single‐pass yields of long‐chain liquid products. These results reveal a wide compositional landscape for Ru promotion and recommend its second‐metal‐content single‐atom alloy limit as the most promising strategy for further catalyst design efforts.
The ubiquitin ligase LONRF2 inhibits glycolysis and malignant phenotypes in endometrial cancer through aldolase A degradation
Erratum: Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743
Biosynthesis of the Selenium-Substituted [FeFe]-Hydrogenases
Topology‐Regulated Polyurea: From Structural Design to Emerging Applications
ABSTRACT As a high‐performance elastomeric material, polyurea has attracted considerable attention for use in impact protection, functional coatings, adhesives, and flexible electronics, primarily owing to its excellent mechanical properties, exceptional high‐strain‐rate response, and chemically tunable molecular architecture. However, the widespread development of polyurea is constrained by several inherent challenges, including the excessively rapid reaction kinetics between isocyanates and amines, limited control of network topology, and restricted functional diversity. In recent years, advances derived from polymer science have enabled notable progress in addressing these limitations. A series of new strategies has been proposed, such as employing low‐reactivity amines or blocking approaches to modulate reaction kinetics, precisely engineering network topology, and systematically broadening the potential application scope. Despite these advances, comprehensive and up‐to‐date reviews that integrate polyurea synthesis methods, topological structural design principles, and application development remain relatively scarce. This review systematically summarizes recent progress in topology‐regulated polyurea, covering its synthesis, preparation, and emerging applications and analyzes the design principles of polyurea's topological structure to clarify key structure–property–performance relationships. Additionally, the review comprehensively outlines cutting‑edge advances in polyurea applications across diverse fields and discusses the main challenges and future prospects for developing next‑generation, high‑performance, and multifunctional polyurea materials.
Deletion of a YEDL sequence in SLC35D3 perturbs its targeting to platelet dense granule precursors
Impact of a comprehensive multidisciplinary tumor board program on treatment decision-making and patient compliance in a tertiary care hospital in Thailand.
324 Background: Multidisciplinary Tumor Boards (MTBs) are integral to quality cancer care, promoting evidence-based treatment through collaborative decision-making. While benefits are well established in Western settings, data from Southeast Asian tertiary hospitals serving diverse patients remain limited. This study evaluates the impact of a comprehensive tumor board program at a private tertiary hospital in Bangkok, Thailand. Methods: A retrospective review was conducted of all cases discussed at institutional tumor boards from January 2021–December 2025. The program includes four boards: Multidisciplinary Tumor Boards (MDT), Molecular Tumor Boards (MTB), Bumrungrad Lung Cancer Consortium (BLCC), and Palliative Oncology Tumor Board (POTB). Data included patient demographics, cancer type, stage, board category, treatment recommendations, compliance, and reasons for non-compliance. Tumor board impact was classified as no change, assisted treatment decision, altered treatment, further diagnostic workup, or de novo treatment planning. Results: A total of 1,391 cases were reviewed over five years. The population comprised 55% international patients, 32% Thai nationals, and 13% expatriates. Major malignancies were lung (20.9%), breast (10.7%), colon (7.1%), hepatobiliary (6.2%), rectal (4.7%), prostate (4.2%), and pancreatic (4.2%) cancers, with over 60 cancer types represented. Most cases were stage IV (54.2%) or stage III (10.1%). Distribution by board: MDT 75.5%, MTB 18.2%, BLCC 3.6%, and POTB 2.7%. Annual utilization was consistent (212–313 cases/year). Among 171 evaluable cases, tumor board impact showed clinical significance—38.6% led to actionable changes: altered treatment (7.0%), aided decisions (14.0%), or required further diagnostics (17.0%); 0.6% were fully directed by board recommendations. No change was noted in 61.4%, validating prior management. Compliance with recommendations was high (87.1%). Among non-compliant cases (12.9%), main reasons were loss to follow-up (69.5%), treatment elsewhere (13.8%), management abroad (3.4%), and refusal of proposed treatment (6.3%). Conclusions: This 5-year analysis demonstrates that a structured tumor boards in a Southeast Asian tertiary setting enhance multidisciplinary decision-making, influencing management in nearly 40% of cases and achieving strong treatment compliance. Specialized tumor boards (molecular, lung consortium, palliative) complement general MDT functions, addressing complex genomic, disease-specific, and end-of-life care needs. Non-compliance was mainly patient related factor rather than disagreement with recommendations. These findings support the value of comprehensive MTBs in Southeast Asian tertiary care settings managing diverse cancer populations with high disease burden and rare cancers.
Switching Hydrogen Transfer Pathway Over Paddle‐Wheel Dicopper Molecular Catalysts for Efficient Electrocatalytic Acetylene Semihydrogenation
ABSTRACT Elucidating the hydrogen transfer pathway of electrocatalytic acetylene semihydrogenation (EAH) is crucial for understanding the catalytic mechanism and designing high‐performance catalysts, but faces grand challenges. Herein, we unprecedentedly switch the hydrogen transfer pathway between Eley‐Rideal mechanism and Langmuir‐Hinshelwood mechanism over paddle‐wheel dicopper molecular catalysts, where the charge density of the Cu sites is effectively modulated by the ligands with different electron‐withdrawing ability. Extended X‐ray absorption fine structure (EXAFS), operando characterizations, and theoretical calculations together reveal that the moderate charge density of Cu sites in benzoic acid‐Cu catalyst (BA‐Cu) inhibits H 2 O dissociation and reduces C 2 H 2 adsorption energy, promoting the co‐adsorption of C 2 H 2 and H 2 O and steering the EAH through the Eley‐Rideal mechanism. In acetic acid‐Cu (AA‐Cu) with low charge density and monofluorobenzoic acid‐Cu (MFBA‐Cu) with high charge density, the Cu sites facilitate H 2 O dissociation to *H and hydrogenate C 2 H 2 via the Langmuir‐Hinshelwood mechanism. In 1 M KOH aqueous solution, the BA‐Cu delivers an ethylene partial current density of 328 mA/cm 2 with an ethylene Faradaic efficiency (FE) of 96.4% at –0.9 V versus RHE, which is about 2‐fold and 1.4‐fold higher than AA‐Cu and MFBA‐Cu. This work provides mechanistic insights for the rational design of high‐performance electrocatalysts by regulating the hydrogenation kinetics.
The Src family kinase YES regulates DNAJB6b chaperone activity to modulate tau aggregation in Alzheimer’s disease
Subtype-specific cell-surface glycocalyx–associated molecular expression programs revealed by public single-cell RNA sequencing in breast cancer.
62 Background: The cell-surface glycocalyx (GCX) is a carbohydrate-rich layer covering epithelial cells and plays an important role in tumor–microenvironment interactions and immune modulation. In breast cancer, GCX remodeling has been implicated in tumor heterogeneity and disease progression. However, integrated analyses linking GCX-associated morphological features with underlying molecular expression programs at the single-cell level across breast cancer subtypes remain limited. We have previously investigated GCX alterations in breast cancer using lectin staining and scanning electron microscopy (SEM). Methods: Frozen sections of resected breast cancer tissues and adjacent normal mammary epithelium were analyzed using multiple fluorescently labeled lectins to profile cell-surface glycan patterns. GCX ultrastructure was further evaluated by SEM using lanthanum nitrate staining. To elucidate the molecular basis underlying GCX phenotypes, publicly available breast cancer single-cell RNA sequencing (scRNA-seq) datasets were analyzed. Tumor epithelial cell populations were extracted, and expression programs of GCX-associated molecules, including glycosylation-related enzymes, mucins, and proteoglycans, were evaluated in a subtype-specific manner. Transcriptomic findings were integrated with lectin-based glycan patterns observed in frozen tissue sections. Results: Lectin staining demonstrated altered cell-surface glycan distribution and marked intratumoral heterogeneity in breast cancer tissues compared with normal mammary epithelium. Reduced binding of O-glycan–associated lectins was observed in tumor regions, indicating GCX remodeling, with patterns differing among breast cancer subtypes. SEM analysis revealed thinning, discontinuity, and surface irregularities of the GCX in tumor areas, consistent with lectin-based observations. Analysis of public scRNA-seq data revealed subtype-associated differences in the expression of GCX-related genes within tumor epithelial cell populations, including genes involved in glycosylation, mucin production, and proteoglycan biology. These transcript-level differences paralleled the subtype-dependent glycan distributions identified by lectin staining. Conclusions: By integrating lectin-based GCX profiling and SEM with public single-cell transcriptomic analysis, we mapped cell-surface glycocalyx phenotypes to corresponding molecular expression programs in breast cancer. GCX remodeling identified by lectin staining was associated with subtype-specific transcriptional programs at the single-cell level. This integrative approach provides a framework for understanding GCX-related tumor heterogeneity and may facilitate future studies on subtype-specific tumor biology and tumor–immune interactions in breast cancer.
Pressure-Induced Stabilization of Terbium(IV) in CsTb(CrO <sub>4</sub> ) <sub>2</sub> Characterized by X-ray Absorption Spectroscopy
Soft Hardware, Flowing Software: Reconfigurable Microfluidics for Adaptable Chemical Computation
ABSTRACT Chemical and physical computing systems promise information processing in performance regimes inaccessible to conventional electronics. However, they are typically constrained by static hardware architectures that limit adaptability and computational richness. Here, we introduce a reconfigurable microfluidic platform where soft hydrogel structures are 3D‐printed and erased in situ to dynamically reshape the physical environment in which chemical computation occurs. By treating microfluidic geometry as an active, programmable element rather than a passive container, we demonstrate hardware‐reconfigurable control over chemical information processing. We demonstrate switchable Deoxyribonucleic acid (DNA) logic gates that alternate between AND and OR functionality without modifying the underlying reaction network, decoupling logic function from molecular composition. Extending this to a non‐equilibrium chemical reaction network in the form of a feedback‐controlled pH oscillator, we demonstrate that printed structures steer reaction kinetics and spatial pattern formation, giving rise to geometry‐dependent spatiotemporal states. Leveraging these dynamics, we implement a physical reservoir computer in which reconfigurable microfluidic hardware enables the realization of diverse nonlinear functions through simple linear readout. Our work establishes reconfigurable soft microfluidic hardware as a control layer for chemical computation, highlighting how adaptable physical environments actively expand the computational state space of chemical software.
Does SLC17A9 (VNUT) function as a stand-alone nucleotide and/or phosphate transporter?
Hepatic arterial infusion chemotherapy combined with transcatheter chemoembolization, camrelizumab, and apatinib for BCLC stage C hepatocellular carcinoma: A retrospective study.
295 Background: This study assessed the combination of hepatic arterial infusion chemotherapy (HAIC), transcatheter chemoembolization (TACE), camrelizumab, and apatinib in patients with BCLC stage C hepatocellular carcinoma (HCC). Methods: This retrospective study was approved by the Ethics Committee of the First Hospital of Jilin University. Patients were included if they had: (1) BCLC stage C HCC; (2) treatment between December 2023 and January 2026; (3) receipt of HAIC, TACE, camrelizumab, and apatinib; (4) complete treatment and follow-up records. The primary outcome was progression-free survival (PFS). Secondary outcomes included overall survival (OS), objective response rate (ORR), disease control rate (DCR), and safety. Results: Fifty-one patients were included: 84.3% male, 66.7% age < 65 years, 66.7% HBV, 13.7% HCV. PVTT distribution: Vp2 (11.8%), Vp3 (60.8%), Vp4 (27.5%). Extrahepatic metastases occurred in 17.6%; tumor diameter ≥7 cm in 54.9%. Child-Pugh A: 66.7%, B: 33.3%. CNLC stage IIIa: 80.4%, IIIb: 19.6%. Median PFS was 4.2 months (95% CI 2.5–7.9); median OS was 12.9 months (95% CI 8.9–NA). ORR was 43.1% and DCR 49.0% (22 partial responses, 3 stable disease). Grade ≥3 laboratory abnormalities related to interventional therapy included elevated ALT, elevated AST, anemia, and decreased white blood cell count; those related to systemic therapy included elevated ALT, elevated AST, elevated bilirubin, anemia, and decreased white blood cell count. No treatment-related deaths occurred. Conclusions: The combination of HAIC, TACE, camrelizumab, and apatinib showed encouraging efficacy and acceptable safety in BCLC stage C HCC. Prospective randomized trials are warranted.
Computational Exploration of Molecular Solar Thermal Energy Storage via Substituted Anthracenes [4 + 4] Photodimerizations and Thermal Retro-Cycloadditions in Solution and Crystalline States
Compact Solvation Enables Sub‐Minute Sodium‐Ion Storage: A Data‐Driven Perspective
ABSTRACT Extremely fast charging (XFC) of batteries holds significant importance in the era of intelligent technologies, yet the intricate role of electrolyte properties in determining XFC behavior remains obscure. Furthermore, conventional theories and in situ characterization techniques fails to elucidate electrochemical behaviors under sub‐minute‐level charging conditions. Herein, we report a data‐driven approach for analyzing the effect of each independent physical and solvation property on sub‐minute‐level sodium‐ion storage behavior. Causal graph analysis reveals that the size of the solvation clusters shows the strongest negative correlation with ultrafast Na + storage in graphite. The optimized compact solvation electrolyte demonstrates an astonishing extreme current density of 250 A g −1 (corresponding to a power density of 46.78 kW kg −1 graphite ) and an unprecedented cycle life of 100 000 cycles. Most notably, the graphite||Na 4 Fe 3 (PO 4 ) 2 P 2 O 7 full batteries achieve stable sub‐minute‐level charging and discharging, exhibiting ultrahigh rate capabilities (up to 200 C, ∼3.4 s per charge) and ultra‐stable cycle performance (24 000 cycles at 50 C, ∼29 s per charge). This work provides a promising pathway for the development of XFC battery, pioneering an innovative assessment strategy for next‐generation electrolytes.
Cryo-EM structure of the complex between transglutaminase 2 and the 45 kDa domain of fibronectin
Treatment timelines, care delivery gaps, and their impact on outcomes in postoperative radiotherapy for head and neck cancer.
229 Background: Delays in treatment have been associated with inferior outcomes in head and neck squamous cell carcinoma (HNSCC). The study aimed to evaluate the impact of treatment timelines on clinical outcomes in patients with HNSCC receiving post-operative radiotherapy (PORT) and to identify patient-related, treatment-related and system-level contributors to treatment delay. Methods: This retrospective study included consecutive patients with HNSCC who completed PORT at our centre from 2021 to 2024. Electronic medical records were reviewed to collect clinical data, treatment timelines, outcomes, and reasons for treatment delays. Survival outcomes were estimated using the Kaplan–Meier method, and multivariable Cox proportional hazards regression was performed to evaluate factors associated with disease-free survival. Results: 1287 patients were eligible for the analysis, with the majority being diagnosed with oral cavity cancer (92.4%). The median interval from surgery to initiation of PORT was 44 days [Interquartile range (IQR), 38-52], with 43% of patients starting PORT within 42 days. The treatment package time (defined as time from surgery to completion of PORT) was <100 days in 1087 (84.5%) patients, with a median time of 87 days (IQR 77-96). At a median follow-up of 20 months, the 2-year locoregional control and disease-free survival (DFS) were 80% and 69%, respectively. On multivariable analysis, T4 disease HR 1.04, 95% CI 1.00–1.07; p = 0.036), N2-3 disease (HR 2.11, 95% CI 1.71–2.61; p < 0.001), and TPT≥ 100 days HR 1.42, 95% CI 1.09–1.84; p = 0.009) were independently associated with worse DFS. Prolonged TPT was predominantly attributable to modifiable factors, including wound-related complications (33.5%), socioeconomic barriers (31.5%), machine-related delays (19%), and delayed referral, especially among patients operated outside the institute (15.5%). Among patients with socioeconomic-related delays, financial constraints, travel distance, and accommodation challenges were the most common contributors. Conclusions: Prolonged treatment package time was independently associated with inferior DFS and was largely attributable to modifiable care delivery barriers such as wound-related complications, socioeconomic barriers, logistical limitations and referral delays. These findings highlight that improving care coordination, strengthening patient support systems, and streamlining referral processes may help reduce delays and improve clinical outcomes.